Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy
Zhong‐Wei Luo, Panpan Liu, Zhen‐Xing Wang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 63

Showing 26-50 of 63 citing articles:

The neutrophil extracellular trap-related gene FPR1 (formyl peptide receptor 1) as a potential prognostic and therapeutic target in osteosarcoma
Shihao Li, Qiong Yuan, Yuanyuan Zhang, et al.
BMC Musculoskeletal Disorders (2025) Vol. 26, Iss. 1
Open Access
Advancements in Osteosarcoma Therapy: Overcoming Chemotherapy Resistance and Exploring Novel Pharmacological Strategies
Mahmoud Zhra, Shahid Akhtar Akhund, Khalid S. Mohammad
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 520-520
Open Access
Exploratory Analysis of Molecular Subtypes in Early-Stage Osteosarcoma: Identifying Resistance and Optimizing Therapy
Luka Bojic, Mina Perić, J Karanović, et al.
Cancers (2025) Vol. 17, Iss. 10, pp. 1677-1677
Open Access
Hypoxia‐Inducible Factor‐2α Signaling in the Skeletal System
Sarah V. Mendoza, Damian C. Genetos, Clare E. Yellowley
JBMR Plus (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 8
From biology to personalized medicine: Recent knowledge in osteosarcoma
Audrey Mohr, Maria Eugénia Marques Da Costa, Olivia Fromigué, et al.
European Journal of Medical Genetics (2024) Vol. 69, pp. 104941-104941
Open Access | Times Cited: 3
Identification of a Novel Prognostic Gene Signature From the Immune Cell Infiltration Landscape of Osteosarcoma
Lei Fan, Jingtao Ru, Tao Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 19
Histotripsy Ablation of Spontaneously Occurring Canine Bone Tumors
Lauren Ruger, Alayna N. Hay, Jessica M. Gannon, et al.
IEEE Transactions on Biomedical Engineering (2022) Vol. 70, Iss. 1, pp. 331-342
Open Access | Times Cited: 14
Comparative Evaluation of Tumor-Infiltrating Lymphocytes in Companion Animals: Immuno-Oncology as a Relevant Translational Model for Cancer Therapy
Christopher J. Pinard, Andrew Lagree, Fang‐I Lu, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5008-5008
Open Access | Times Cited: 13
SKP2 Knockout in Rb1/p53–Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis
Alexander Ferrena, Jichuan Wang, Ranxin Zhang, et al.
Molecular Cancer Therapeutics (2023) Vol. 23, Iss. 2, pp. 223-234
Open Access | Times Cited: 8
Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients
Max Baron, Philip Drohat, Brooke Crawford, et al.
Bioengineering (2023) Vol. 10, Iss. 10, pp. 1187-1187
Open Access | Times Cited: 7
Ablative and Immunostimulatory Effects of Histotripsy Ablation in a Murine Osteosarcoma Model
Alayna N. Hay, Khan Mohammad Imran, Alissa Hendricks-Wenger, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2737-2737
Open Access | Times Cited: 7
Omentin-1 inhibits the development of benign prostatic hyperplasia by attenuating local inflammation
Yiyi Wang, Guo‐Qiang Zhu, Kun Xia, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma
Sabeena Giri, Kevin J. Allen, Chandra Bose Prabaharan, et al.
Nuclear Medicine and Biology (2024) Vol. 134-135, pp. 108917-108917
Open Access | Times Cited: 2
Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis
Н. М. Тодосенко, И. А. Хлусов, K. А. Yurova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8993-8993
Open Access | Times Cited: 6
The Heterogeneity of Infiltrating Macrophages in Metastatic Osteosarcoma and Its Correlation with Immunotherapy
Zhanchao Wang, Huiqiao Wu, Yu Chen, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 14
Onionin A inhibits small-cell lung cancer proliferation through suppressing STAT3 activation induced by macrophages-derived IL-6 and cell–cell interaction with tumor-associated macrophage
Remi Mito, Toyohisa Iriki, Yukio Fujiwara, et al.
Human Cell (2023) Vol. 36, Iss. 3, pp. 1068-1080
Open Access | Times Cited: 5
Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma
Nicoletta Nastasi, Amada Pasha, Gennaro Bruno, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4744-4744
Open Access | Times Cited: 4
In vitro and in vivo killing effects of methionine enkephalin on osteosarcoma
Hai Huang, Xiaonan Wang, Shuling Zhang, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111226-111226
Closed Access | Times Cited: 4
Modeling 3D Tumor Invasiveness to Modulate Macrophage Phenotype in a Human‐Based Hydrogel Platform
Cátia F. Monteiro, Catarina R. Almeida, Catarina A. Custódio, et al.
Macromolecular Bioscience (2024) Vol. 24, Iss. 11
Closed Access | Times Cited: 1
Recent progress in diagnostic imaging and therapeutics of osteosarcoma based on multifunctional nanoparticles
Xueke Yan, Danmin Lin, Dingyuan Yan, et al.
Science China Chemistry (2024) Vol. 67, Iss. 9, pp. 2864-2889
Closed Access | Times Cited: 1
Evaluation of the Chemotherapy Drug Response Using Organotypic Cultures of Osteosarcoma Tumours from Mice Models and Canine Patients
Bénédicte Brulin, John Nolan, Tecla Marangon, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4890-4890
Open Access | Times Cited: 9
Immune-based prognostic biomarkers associated with metastasis of osteosarcoma
Teng Ma, Changliang Peng, Wu D, et al.
General Physiology and Biophysics (2023) Vol. 42, Iss. 01, pp. 1-12
Open Access | Times Cited: 3
Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas
Halin Bareke, Adrián Ibáñez-Navarro, Pilar Guerra‐García, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8324-8324
Open Access | Times Cited: 3
SKP2 knockout in Rb1/p53 deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosis
Alexander Ferrena, Jichuan Wang, Ranxin Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Single-cell RNA sequencing reveals the immune microenvironment landscape of osteosarcoma before and after chemotherapy
Yun Liu, Yunhua Lin, Shijie Liao, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23601-e23601
Open Access | Times Cited: 3

Scroll to top